Peroxisome proliferator-activated receptors: insight into multiple cellular functions

Mangelsdorf, 1995, The nuclear receptor superfamily: the second decade, Cell, 83, 835, 10.1016/0092-8674(95)90199-X

Beato, 1995, Steroid hormone receptors: many actors in search of a plot, Cell, 83, 851, 10.1016/0092-8674(95)90201-5

Kastner, 1995, Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life?, Cell, 83, 859, 10.1016/0092-8674(95)90202-3

Keller, 1997, Steroid hormone and related receptors, 255, 10.1016/S1569-2582(97)80037-2

Blumberg, 1998, Orphan nuclear receptors — new ligands and new possibilities, Genes Dev., 12, 3149, 10.1101/gad.12.20.3149

Green, 1988, Nuclear receptors enhance our understanding of transcription regulation, Trends Genet., 4, 309, 10.1016/0168-9525(88)90108-4

Evans, 1988, The steroid and thyroid hormone receptor superfamily, Science, 240, 889, 10.1126/science.3283939

Issemann, 1990, Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators, Nature, 347, 645, 10.1038/347645a0

Dreyer, 1992, Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors, Cell, 68, 879, 10.1016/0092-8674(92)90031-7

1999, A unified nomenclature system for the nuclear receptor superfamily, Cell, 97, 161, 10.1016/S0092-8674(00)80726-6

Desvergne, 1995, PPAR: a key nuclear factor in nutrient/gene interactions?, Vol. 1, 142

Lemberger, 1996, Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology, Annu. Rev. Cell Dev. Biol., 12, 335, 10.1146/annurev.cellbio.12.1.335

Escriva, 1997, Ligand binding was acquired during evolution of nuclear receptors, Proc. Natl. Acad. Sci. U.S.A., 94, 6803, 10.1073/pnas.94.13.6803

Kliewer, 1994, Differential expression and activation of a family of murine peroxisome proliferator-activated receptors, Proc. Natl. Acad. Sci. U.S.A., 91, 7355, 10.1073/pnas.91.15.7355

Sher, 1993, cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor, Biochemistry, 32, 5598, 10.1021/bi00072a015

Schmidt, 1992, Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids, Mol. Endocrinol., 6, 1634, 10.1210/me.6.10.1634

Greene, 1995, Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping, Gene Expression, 4, 281

Jones, 1995, Chromosomal localisation, inducibility, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated-receptor genes, Eur. J. Biochem., 233, 219, 10.1111/j.1432-1033.1995.219_1.x

Yoshikawa, 1996, Assignment of the human nuclear hormone receptor, NUC1 (PPARdelta), to chromosome 6p21.1–p21.2, Genomics, 35, 637, 10.1006/geno.1996.0417

Krey, 1993, Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids, J. Steroid Biochem. Mol. Biol., 47, 65, 10.1016/0960-0760(93)90058-5

Gearing, 1994, Structure of the mouse peroxisome proliferator activated receptor alpha gene, Biochem. Biophys. Res. Commun., 199, 255, 10.1006/bbrc.1994.1222

Zhu, 1995, Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms, Proc. Natl. Acad. Sci. U.S.A., 92, 7921, 10.1073/pnas.92.17.7921

Fajas, 1997, The organization, promoter analysis, and expression of the human PPARgamma gene, J. Biol. Chem., 272, 18779, 10.1074/jbc.272.30.18779

Fajas, 1998, PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter, FEBS Lett., 438, 55, 10.1016/S0014-5793(98)01273-3

Shalev, 1996, The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin, Endocrinology, 137, 4499, 10.1210/en.137.10.4499

Juge-Aubry, 1999, Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain, J. Biol. Chem., 274, 10505, 10.1074/jbc.274.15.10505

Zhang, 1996, Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma, J. Biol. Chem., 271, 31771, 10.1074/jbc.271.50.31771

Camp, 1997, Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase, J. Biol. Chem., 272, 10811, 10.1074/jbc.272.16.10811

Adams, 1997, Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site, J. Biol. Chem., 272, 5128, 10.1074/jbc.272.8.5128

Hu, 1996, Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma, Science, 274, 2100, 10.1126/science.274.5295.2100

Shao, 1998, Interdomain communication regulating ligand binding by PPAR-gamma, Nature, 396, 377, 10.1038/24634

Tontonoz, 1994, Stimulation of adipogenesis in fibroblasts by PPARgamma 2, a lipid-activated transcription factor, Cell, 79, 1147, 10.1016/0092-8674(94)90006-X

Deeb, 1998, A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity, Nat. Genet., 20, 284, 10.1038/3099

Härd, 1990, Solution structure of the glucocorticoid receptor DNA-binding domain, Science, 249, 157, 10.1126/science.2115209

Luisi, 1991, Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA, Nature, 352, 497, 10.1038/352497a0

Schwabe, 1990, Solution structure of the DNA-binding domain of the oestrogen receptor, Nature, 348, 458, 10.1038/348458a0

Lee, 1993, Structure of the retinoid X receptor alpha DNA binding domain: a helix required for homodimeric DNA binding, Science, 260, 1117, 10.1126/science.8388124

Schwabe, 1993, The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements, Cell, 75, 567, 10.1016/0092-8674(93)90390-C

Martinez, 1991, Characterization of hormone response elements, 125

Mangelsdorf, 1995, The RXR heterodimers and orphan receptors, Cell, 83, 841, 10.1016/0092-8674(95)90200-7

Zechel, 1994, The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats, EMBO J., 13, 1425, 10.1002/j.1460-2075.1994.tb06396.x

Rastinejad, 1995, Structural determinants of nuclear receptor assembly on DNA direct repeats, Nature, 375, 203, 10.1038/375203a0

Myers, 1997, Amino acid residues in both the DNA-binding and ligand-binding domains influence transcriptional activity of the human peroxisome proliferator-activated receptor alpha, Biochem. Biophys. Res. Commun., 239, 522, 10.1006/bbrc.1997.7507

Kliewer, 1992, Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors, Nature, 358, 771, 10.1038/358771a0

Tugwood, 1992, The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene, EMBO J., 11, 433, 10.1002/j.1460-2075.1992.tb05072.x

Keller, 1993, Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers, Proc. Natl. Acad. Sci. U.S.A., 90, 2160, 10.1073/pnas.90.6.2160

Jpenberg, 1997, Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element, J. Biol. Chem., 272, 20108, 10.1074/jbc.272.32.20108

Juge-Aubry, 1997, DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region, J. Biol. Chem., 272, 25252, 10.1074/jbc.272.40.25252

Hsu, 1998, A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding, J. Biol. Chem., 273, 27988, 10.1074/jbc.273.43.27988

Xu, 1999, Molecular recognition of fatty acids by peroxisome proliferator-activated receptors, Mol. Cell, 3, 397, 10.1016/S1097-2765(00)80467-0

Nolte, 1998, Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma, Nature, 395, 137, 10.1038/25931

Uppenberg, 1998, Crystal structure of the ligand binding domain of the human nuclear receptor PPARgamma, J. Biol. Chem., 273, 31108, 10.1074/jbc.273.47.31108

Hsu, 1995, A single amino acid change in the mouse peroxisome proliferator-activated receptor alpha alters transcriptional responses to peroxisome proliferators, Mol. Pharmacol., 48, 559

Keller, 1997, PPAR alpha structure-function relationships derived from species-specific differences in responsiveness to hypolipidemic agents, Biol. Chem., 378, 651, 10.1515/bchm.1997.378.7.651

Dowell, 1997, Ligand-induced peroxisome proliferator-activated receptor alpha conformational change, J. Biol. Chem., 272, 2013, 10.1074/jbc.272.3.2013

Juge-Aubry, 1995, Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat, J. Biol. Chem., 270, 18117, 10.1074/jbc.270.30.18117

Feng, 1998, Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors, Science, 280, 1747, 10.1126/science.280.5370.1747

Onate, 1995, Sequence and characterization of a coactivator for the steroid hormone receptor superfamily, Science, 270, 1354, 10.1126/science.270.5240.1354

Spencer, 1997, Steroid receptor coactivator-1 is a histone acetyltransferase, Nature, 389, 194, 10.1038/38304

Krey, 1997, Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay, Mol. Endocrinol., 11, 779, 10.1210/me.11.6.779

Onate, 1998, The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors, J. Biol. Chem., 273, 12101, 10.1074/jbc.273.20.12101

Chakravarti, 1996, Role of CBP/p300 in nuclear receptor signaling, Nature, 383, 99, 10.1038/383099a0

Glass, 1997, Nuclear receptor coactivators, Curr. Opin. Cell Biol., 9, 222, 10.1016/S0955-0674(97)80066-X

Ogryzko, 1996, The transcriptional coactivators p300 and CBP are histone acetyltransferases, Cell, 87, 953, 10.1016/S0092-8674(00)82001-2

Bannister, 1996, The CBP co-activator is a histone acetyltransferase, Nature, 384, 641, 10.1038/384641a0

Dowell, 1997, p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha, J. Biol. Chem., 272, 33435, 10.1074/jbc.272.52.33435

Gelman, 1999, p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively, J. Biol. Chem., 274, 7681, 10.1074/jbc.274.12.7681

Dowell, 1999, Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein, J. Biol. Chem., 274, 15901, 10.1074/jbc.274.22.15901

Oberfield, 1999, A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation, Proc. Natl. Acad. Sci. U.S.A., 96, 6102, 10.1073/pnas.96.11.6102

McKenna, 1998, Distinct steady-state nuclear receptor coregulator complexes exist in vivo, Proc. Natl. Acad. Sci. U.S.A., 95, 11697, 10.1073/pnas.95.20.11697

Puigserver, 1998, A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis, Cell, 92, 829, 10.1016/S0092-8674(00)81410-5

Misiti, 1998, Expression and hormonal regulation of coactivator and corepressor genes, Endocrinology, 139, 2493, 10.1210/en.139.5.2493

Zhu, 1997, Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor, J. Biol. Chem., 272, 25500, 10.1074/jbc.272.41.25500

Jain, 1998, Differential expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse, Am. J. Pathol., 153, 349, 10.1016/S0002-9440(10)65577-0

Willson, 1997, Peroxisome proliferator-activated receptor agonists, Curr. Opin. Chem. Biol., 1, 235, 10.1016/S1367-5931(97)80015-4

Lehmann, 1997, Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs, J. Biol. Chem., 272, 3406, 10.1074/jbc.272.6.3406

Kliewer, 1997, Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma, Proc. Natl. Acad. Sci. U.S.A., 94, 4318, 10.1073/pnas.94.9.4318

Lehmann, 1995, An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma), J. Biol. Chem., 270, 12953, 10.1074/jbc.270.22.12953

Göttlicher, 1992, Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor, Proc. Natl. Acad. Sci. U.S.A., 89, 4653, 10.1073/pnas.89.10.4653

Lin, 1999, Ligand selectivity of the peroxisome proliferator-activated receptor alpha, Biochemistry, 38, 185, 10.1021/bi9816094

Nagy, 1998, Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma, Cell, 93, 229, 10.1016/S0092-8674(00)81574-3

Forman, 1995, 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma, Cell, 83, 803, 10.1016/0092-8674(95)90193-0

Kliewer, 1995, A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation, Cell, 83, 813, 10.1016/0092-8674(95)90194-9

Devchand, 1996, The PPARalpha-leukotriene B4 pathway to inflammation control, Nature, 384, 39, 10.1038/384039a0

Yu, 1995, Differential activation of peroxisome proliferator-activated receptors by eicosanoids, J. Biol. Chem., 270, 23975, 10.1074/jbc.270.41.23975

Forman, 1997, Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta, Proc. Natl. Acad. Sci. U.S.A., 94, 4312, 10.1073/pnas.94.9.4312

Dreyer, 1993, Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR), Biol. Cell, 77, 67, 10.1016/S0248-4900(05)80176-5

Braissant, 1996, Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha,-beta, and-gamma in the adult rat, Endocrinology, 137, 354, 10.1210/en.137.1.354

Ouali, 1998, Dietary lipids regulate beta-oxidation enzyme gene expression in the developing rat kidney, Am. J. Physiol., 275, F777

Cullingford, 1998, Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system, J. Neurochem., 70, 1366, 10.1046/j.1471-4159.1998.70041366.x

Beck, 1992, The ontogeny of peroxisome-proliferator-activated receptor gene expression in the mouse and rat, Proc. R. Soc. London, Ser. B, 247, 83, 10.1098/rspb.1992.0012

Amri, 1995, Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors, J. Biol. Chem., 270, 2367, 10.1074/jbc.270.5.2367

Xing, 1995, Rat PPAR delta contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei, Biochem. Biophys. Res. Commun., 217, 1015, 10.1006/bbrc.1995.2871

Tontonoz, 1994, mPPARgamma2: tissue-specific regulator of an adipocyte enhancer, Genes Dev., 8, 1224, 10.1101/gad.8.10.1224

Mansen, 1996, Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa, Biochem. Biophys. Res. Commun., 222, 844, 10.1006/bbrc.1996.0832

Auboeuf, 1997, Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients, Diabetes, 46, 1319, 10.2337/diabetes.46.8.1319

Mukherjee, 1997, Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists, J. Biol. Chem., 272, 8071, 10.1074/jbc.272.12.8071

Palmer, 1998, Peroxisome proliferator-activated receptor alpha expression in human liver, Mol. Pharmacol., 53, 14, 10.1124/mol.53.1.14

Vidal-Puig, 1997, Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids, J. Clin. Invest., 99, 2416, 10.1172/JCI119424

Schoonjans, 1996, PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene, EMBO J., 15, 5336, 10.1002/j.1460-2075.1996.tb00918.x

Motojima, 1998, Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor a and g activators in a tissue- and inducer-specific manner, J. Biol. Chem., 273, 16710, 10.1074/jbc.273.27.16710

Issemann, 1992, A role for fatty acids and liver fatty acid binding protein in peroxisome proliferation?, Biochem. Soc. Trans., 20, 824, 10.1042/bst0200824

Schoonjans, 1995, Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter, J. Biol. Chem., 270, 19269, 10.1074/jbc.270.33.19269

Zhang, 1992, Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase, Proc. Natl. Acad. Sci. U.S.A., 89, 7541, 10.1073/pnas.89.16.7541

Lee, 1995, Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators, Mol. Cell. Biol., 15, 3012, 10.1128/MCB.15.6.3012

Mascaro, 1998, Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor, J. Biol. Chem., 273, 8560, 10.1074/jbc.273.15.8560

Brandt, 1998, Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha, J. Biol. Chem., 273, 23786, 10.1074/jbc.273.37.23786

Yu, 1998, Co-regulation of tissue-specific alternative human carnitine palmitoyltransferase Ibeta gene promoters by fatty acid enzyme substrate, J. Biol. Chem., 273, 32901, 10.1074/jbc.273.49.32901

Gulick, 1994, The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression, Proc. Natl. Acad. Sci. U.S.A., 91, 11012, 10.1073/pnas.91.23.11012

Rodriguez, 1994, Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids, J. Biol. Chem., 269, 18767, 10.1016/S0021-9258(17)32234-2

Muerhoff, 1992, The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid, J. Biol. Chem., 267, 19051, 10.1016/S0021-9258(18)41738-3

Aldridge, 1995, Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription, Biochem. J., 306, 473, 10.1042/bj3060473

Kroetz, 1998, Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes, J. Biol. Chem., 273, 31581, 10.1074/jbc.273.47.31581

Castelein, 1994, The peroxisome proliferator activated receptor regulates malic enzyme gene expression, J. Biol. Chem., 269, 26754, 10.1016/S0021-9258(18)47083-4

Vu-Dac, 1995, Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor, J. Clin. Invest., 96, 741, 10.1172/JCI118118

Hertz, 1995, Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III, J. Biol. Chem., 270, 13470, 10.1074/jbc.270.22.13470

Sears, 1996, Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: regulation by peroxisome proliferator-activated receptor gamma, Mol. Cell. Biol., 16, 3410, 10.1128/MCB.16.7.3410

Aoyama, 1998, Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha), J. Biol. Chem., 273, 5678, 10.1074/jbc.273.10.5678

Djouadi, 1998, A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor alpha-deficient mice, J. Clin. Invest., 102, 1083, 10.1172/JCI3949

Costet, 1998, Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis, J. Biol. Chem., 273, 29577, 10.1074/jbc.273.45.29577

Lemberger, 1996, Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm, J. Biol. Chem., 271, 1764, 10.1074/jbc.271.3.1764

Lemberger, 1996, PPAR tissue distribution and interactions with other hormone-signaling pathways, Ann. N.Y. Acad. Sci., 231, 10.1111/j.1749-6632.1996.tb18619.x

Cattley, 1998, Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?, Regul. Toxicol. Pharmacol., 8, 125

Peters, 1997, Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643, Carcinogenesis, 18, 2029, 10.1093/carcin/18.11.2029

Karam, 1997, Induction of replicative DNA synthesis and PPAR alpha-dependent gene transcription by Wy-14 643 in primary rat hepatocyte and non-parenchymal cell co-cultures, Carcinogenesis, 18, 2077, 10.1093/carcin/18.11.2077

Roberts, 1998, Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha), Carcinogenesis, 19, 43, 10.1093/carcin/19.1.43

Peters, 1997, Di(2-ethylhexyl) phthalate induces a functional zinc deficiency during pregnancy and teratogenesis that is independent of peroxisome proliferator-activated receptor-alpha, Teratology, 56, 311, 10.1002/(SICI)1096-9926(199711)56:5<311::AID-TERA4>3.0.CO;2-#

Braissant, 1998, Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development, Endocrinology, 139, 2748, 10.1210/en.139.6.2748

Chawla, 1994, Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation, Endocrinology, 135, 798, 10.1210/en.135.2.798

Tontonoz, 1994, Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha, Nucleic Acids Res., 22, 5628, 10.1093/nar/22.25.5628

Tontonoz, 1995, PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene, Mol. Cell. Biol., 15, 351, 10.1128/MCB.15.1.351

Brun, 1996, Differential activation of adipogenesis by multiple PPAR isoforms, Genes Dev., 10, 974, 10.1101/gad.10.8.974

Kim, 1996, ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism, Genes Dev., 10, 1096, 10.1101/gad.10.9.1096

Kim, 1998, ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand, Proc. Natl. Acad. Sci. U.S.A., 95, 4333, 10.1073/pnas.95.8.4333

Spiegelman, 1996, Adipogenesis and obesity: rounding out the big picture, Cell, 87, 377, 10.1016/S0092-8674(00)81359-8

Vidal-Puig, 1996, Regulation of PPAR gamma gene expression by nutrition and obesity in rodents, J. Clin. Invest., 97, 2553, 10.1172/JCI118703

Burant, 1997, Troglitazone action is independent of adipose tissue, J. Clin. Invest., 100, 2900, 10.1172/JCI119839

Ribon, 1998, Thiazolidinediones and insulin resistance: peroxisome proliferator activated receptor gamma activation stimulates expression of the CAP gene, Proc. Natl. Acad. Sci. U.S.A., 95, 14751, 10.1073/pnas.95.25.14751

Michael, 1997, Peroxisome proliferator-activated receptor gamma1 expression is induced during cyclic adenosine monophosphate-stimulated differentiation of alveolar type II pneumonocytes, Endocrinology, 138, 3695, 10.1210/en.138.9.3695

Teboul, 1995, Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells, J. Biol. Chem., 270, 28183, 10.1074/jbc.270.47.28183

Altiok, 1997, PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A, Genes Dev., 11, 1987, 10.1101/gad.11.15.1987

Tontonoz, 1997, Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor, Proc. Natl. Acad. Sci. U.S.A., 94, 237, 10.1073/pnas.94.1.237

Mueller, 1998, Terminal differentiation of human breast cancer through PPAR gamma, Mol. Cell, 1, 465, 10.1016/S1097-2765(00)80047-7

Elstner, 1998, Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice, Proc. Natl. Acad. Sci. U.S.A., 95, 8806, 10.1073/pnas.95.15.8806

Lefebvre, 1998, Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCmin/+ mice, Nat. Med., 4, 1053, 10.1038/2036

Saez, 1998, Activators of the nuclear receptor PPARgamma enhance colon polyp formation, Nat. Med., 4, 1058, 10.1038/2042

Sarraf, 1998, Differentiation and reversal of malignant changes in colon cancer through PPARgamma, Nat. Med., 4, 1046, 10.1038/2030

Tontonoz, 1998, PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL, Cell, 93, 241, 10.1016/S0092-8674(00)81575-5

Ricote, 1998, Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein, Proc. Natl. Acad. Sci. U.S.A., 95, 7614, 10.1073/pnas.95.13.7614

Staels, 1998, Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators, Nature, 393, 790, 10.1038/31701

Poynter, 1998, Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging, J. Biol. Chem., 273, 32833, 10.1074/jbc.273.49.32833

Ricote, 1998, The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation, Nature, 391, 79, 10.1038/34178

Jiang, 1998, PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines, Nature, 391, 82, 10.1038/35154

Zhang, 1996, Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha, Mol. Endocrinol., 10, 1457, 10.1210/me.10.11.1457

Demetri, 1999, Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor gamma ligand troglitazone in patients with liposarcoma, Proc. Natl. Acad. Sci. U.S.A., 96, 3951, 10.1073/pnas.96.7.3951

Mallordy, 1995, Evidence for transcriptional induction of the liver fatty acid-binding protein gene by bezafibrate in the small intestine, Eur. J. Biochem., 227, 801, 10.1111/j.1432-1033.1995.tb20204.x

Shimabukuro, 1998, Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats, J. Biol. Chem., 273, 3547, 10.1074/jbc.273.6.3547